N. D. Chavda Et Al. , "Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT," 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.134, Florida, United States Of America, 2019
Chavda, N. D. Et Al. 2019. Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT. 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).
Chavda, N. D., Robinson, S., Boumendil, A., Khvedelidze, I., Finel, H., Akhtar, S., ... Rauf, M. S.(2019). Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT . 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America
Chavda, Nikesh Et Al. "Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT," 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019
Chavda, Nikesh D. Et Al. "Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT." 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019
Chavda, N. D. Et Al. (2019) . "Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT." 62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Nikesh Dhiraj Chavda Et Al. }, title={Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT}, congress name={62nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}